Boston Partners
TRIB

Boston Partners’s Trinity Biotech TRIB Stock Holding History

Boston Partners’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-90,431
Closed -$1.29M – 700
2019
Q1 		$1.29M Sell
90,431
-18,674
-17% -$257K ﹤0.01% 606
2018
Q4 		$1.25M Sell
109,105
-25,519
-19% -$394K ﹤0.01% 619
2018
Q3 		$2.69M Sell
134,624
-32,528
-19% -$707K ﹤0.01% 567
2018
Q2 		$4.18M Sell
167,152
-3,074
-2% -$73.9K 0.01% 493
2018
Q1 		$4.38M Sell
170,226
-44,618
-21% -$1.22M 0.01% 503
2017
Q4 		$5.49M Sell
214,844
-34,131
-14% -$880K 0.01% 477
2017
Q3 		$6.98M Buy
248,975
+16,196
+7% +$452K 0.01% 449
2017
Q2 		$6.98M Sell
232,779
-28,881
-11% -$818K 0.01% 428
2017
Q1 		$7.8M Sell
261,660
-38,690
-13% -$1.21M 0.01% 426
2016
Q4 		$10.4M Sell
300,350
-12,022
-4% -$414K 0.01% 401
2016
Q3 		$20.6M Sell
312,372
-16,980
-5% -$1.06M 0.03% 317
2016
Q2 		$18.7M Sell
329,352
-1,952
-0.6% -$110K 0.03% 311
2016
Q1 		$19.3M Buy
331,304
+13,312
+4% +$707K 0.03% 299
2015
Q4 		$18.7M Buy
317,992
+8,518
+3% +$503K 0.03% 306
2015
Q3 		$17.7M Buy
309,474
+83,780
+37% +$6.74M 0.03% 308
2015
Q2 		$20.4M Buy
225,694
+59,626
+36% +$5.16M 0.03% 302
2015
Q1 		$16M Buy
166,068
+113,348
+215% +$10.5M 0.02% 338
2014
Q4 		$4.62M Buy
+52,720
New +$4.54M 0.01% 539
2013
Q4 		– Sell
-6,825
Closed -$743K – 729
2013
Q3 		$743K Sell
6,825
-22,230
-77% -$2.17M ﹤0.01% 647
2013
Q2 		$2.45M Buy
+29,055
New +$2.41M 0.01% 574

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Partners's TRIB Position: Q2 2019 in Review

Boston Partners sold out of Trinity Biotech (TRIB) in Q2 2019, closing a stake of 90,431 shares — an estimated $1.29M sold.

Boston Partners first reported a position in TRIB in Q2 2013 and held it in 20 quarters. The position peaked at $20.6M in Q3 2016. 35 funds tracked by Wall St. Rank hold TRIB as of Q2 2019.

  • Boston Partners reported no remaining Trinity Biotech position as of Q2 2019 after selling out during the quarter.
  • Boston Partners sold 90,431 Trinity Biotech shares in Q2 2019, an estimated $1.29M.
  • Boston Partners first reported a position in Trinity Biotech in Q2 2013 and held it in 20 quarters.
  • Boston Partners's Trinity Biotech position peaked at $20.6M in Q3 2016.
  • 35 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2019.

Based on Boston Partners's 13F filing for Q2 2019, filed 9 Aug 2019.